Adam Scott Levy - Net Worth and Insider Trading
Adam Scott Levy Net Worth
The estimated net worth of Adam Scott Levy is at least $3 Million dollars as of 2024-11-29. Adam Scott Levy is the CFO and Secretary of Mineralys Therapeutics Inc and owns about 236,854 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $3 Million. Adam Scott Levy is also the Chief Business Officer of Viridian Therapeutics Inc and owns about 703 shares of Viridian Therapeutics Inc (VRDN) stock worth over $15,375. Details can be seen in Adam Scott Levy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adam Scott Levy has not made any transactions after 2024-10-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adam Scott Levy
Adam Scott Levy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adam Scott Levy owns 3 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) , Viridian Therapeutics Inc (VRDN) , and Mineralys Therapeutics Inc (MLYS) .
Click here to see the complete history of Adam Scott Levy’s form 4 insider trades.
Insider Ownership Summary of Adam Scott Levy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2019-08-31 | Chief Business Officer |
| VRDN | Viridian Therapeutics Inc | 2018-02-13 | Chief Business Officer |
| MLYS | Mineralys Therapeutics Inc | 2024-10-11 | CFO & Chief Bus. Off. and Secy. |
Adam Scott Levy Latest Holdings Summary
Adam Scott Levy currently owns a total of 2 stocks. Among these stocks, Adam Scott Levy owns 236,854 shares of Mineralys Therapeutics Inc (MLYS) as of October 11, 2024, with a value of $3 Million and a weighting of 99.51%. Adam Scott Levy also owns 703 shares of Viridian Therapeutics Inc (VRDN) as of February 13, 2018, with a value of $15,375 and a weighting of 0.49%.
Latest Holdings of Adam Scott Levy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2024-10-11 | 236,854 | 13.11 | 3,105,156 |
| VRDN | Viridian Therapeutics Inc | 2018-02-13 | 703 | 21.87 | 15,375 |
Holding Weightings of Adam Scott Levy
Adam Scott Levy Form 4 Trading Tracker
According to the SEC Form 4 filings, Adam Scott Levy has made a total of 4 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Mineralys Therapeutics Inc is the sale of 10,757 shares on October 11, 2024, which brought Adam Scott Levy around $145,972.
According to the SEC Form 4 filings, Adam Scott Levy has made a total of 0 transactions in Viridian Therapeutics Inc (VRDN) over the past 5 years. The most-recent trade in Viridian Therapeutics Inc is the acquisition of 606 shares on February 13, 2018, which cost Adam Scott Levy around $49,995.
Insider Trading History of Adam Scott Levy
- 1
Adam Scott Levy Trading Performance
GuruFocus tracks the stock performance after each of Adam Scott Levy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adam Scott Levy is 14.53%. GuruFocus also compares Adam Scott Levy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adam Scott Levy within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adam Scott Levy's insider trading performs compared to the benchmark.
Performance of Adam Scott Levy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.5 | | | | | |
| Relative Return to S&P 500(%) | 34.44 | | | | | |
Adam Scott Levy Ownership Network
Adam Scott Levy Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Adam Scott Levy is the Chief Business Officer of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Adam Scott Levy made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Adam Scott Levy Mailing Address
Above is the net worth, insider trading, and ownership report for Adam Scott Levy. You might contact Adam Scott Levy via mailing address: C/o Miragen Therapeutics, Inc., 6200 Lookout Road, #100, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
